Literature DB >> 6373305

Antigenic polymorphism of Trypanosoma cruzi: clonal analysis of trypomastigote surface antigens.

F Plata, F Garcia Pons, H Eisen.   

Abstract

The surface membrane antigens of infectious Trypanosoma cruzi trypomastigotes were studied at the levels of the strain and of individual trypomastigote clones. Blood trypomastigotes from three T. cruzi strains, Y, CL and Tehuantepec ("Teh"), were grown in vitro by weekly infection of J774 mouse macrophage tumor cells. Each T. cruzi strain was subsequently cloned by infection of J774 cells at limited trypomastigote dilution, and antisera were produced in mice against a selection of trypomastigote clones. Criss-cross panel analyses indicated the existence of a large degree of polymorphism among trypomastigote surface antigens. Various trypomastigote surface antigens were cross-reactive, appeared to be highly conserved, and were common to the three strains considered and to all the clones derived from each strain. Analysis by sodium dodecyl sulfate polyacrylamide gel electrophoresis showed that numerous trypomastigote antigenic proteins were precipitated by mouse antisera generated against cloned trypomastigotes. Some of these proteins were commonly distributed, while others were polymorphic. Finally, a state of cross-reactive immunity could be induced in C3H/He mice by infection with a cloned T. cruzi trypomastigote population. Immune mice resisted subsequent infections with lethal doses of wild-type bloodstream trypomastigotes from any one of the three T. cruzi strains.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6373305     DOI: 10.1002/eji.1830140503

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  21 in total

1.  Isolation and characterization of glycosylphosphatidylinositol-anchored, mucin-like surface glycoproteins from bloodstream forms of the freshwater-fish parasite Trypanosoma carassii.

Authors:  A Lischke; C Klein; Y D Stierhof; M Hempel; A Mehlert; I C Almeida; M A Ferguson; P Overath
Journal:  Biochem J       Date:  2000-02-01       Impact factor: 3.857

2.  Gene expression analysis in mitochondria from chagasic mice: alterations in specific metabolic pathways.

Authors:  Nisha Garg; Arpad Gerstner; Vandanajay Bhatia; James DeFord; John Papaconstantinou
Journal:  Biochem J       Date:  2004-08-01       Impact factor: 3.857

3.  NADPH oxidase inhibition ameliorates Trypanosoma cruzi-induced myocarditis during Chagas disease.

Authors:  Monisha Dhiman; Nisha Jain Garg
Journal:  J Pathol       Date:  2011-09-26       Impact factor: 7.996

4.  The major surface glycoprotein of Trypanosoma cruzi amastigotes are ligands of the human serum mannose-binding protein.

Authors:  S J Kahn; M Wleklinski; R A Ezekowitz; D Coder; A Aruffo; A Farr
Journal:  Infect Immun       Date:  1996-07       Impact factor: 3.441

5.  The major 85-kDa surface antigen of the mammalian-stage forms of Trypanosoma cruzi is a family of sialidases.

Authors:  S Kahn; T G Colbert; J C Wallace; N A Hoagland; H Eisen
Journal:  Proc Natl Acad Sci U S A       Date:  1991-05-15       Impact factor: 11.205

6.  Both CD1d antigen presentation and interleukin-12 are required to activate natural killer T cells during Trypanosoma cruzi infection.

Authors:  Malcolm S Duthie; Maria Kahn; Maria White; Raj P Kapur; Stuart J Kahn
Journal:  Infect Immun       Date:  2005-03       Impact factor: 3.441

7.  During acute Trypanosoma cruzi infection highly susceptible mice deficient in natural killer cells are protected by a single alpha-galactosylceramide treatment.

Authors:  Malcolm S Duthie; Stuart J Kahn
Journal:  Immunology       Date:  2006-07-26       Impact factor: 7.397

8.  Trypanosoma cruzi amastigote adhesion to macrophages is facilitated by the mannose receptor.

Authors:  S Kahn; M Wleklinski; A Aruffo; A Farr; D Coder; M Kahn
Journal:  J Exp Med       Date:  1995-11-01       Impact factor: 14.307

9.  Increased myeloperoxidase activity and protein nitration are indicators of inflammation in patients with Chagas' disease.

Authors:  Monisha Dhiman; Jose Guillermo Estrada-Franco; Jasmine M Pando; Francisco J Ramirez-Aguilar; Heidi Spratt; Sara Vazquez-Corzo; Gladys Perez-Molina; Rosa Gallegos-Sandoval; Roberto Moreno; Nisha Jain Garg
Journal:  Clin Vaccine Immunol       Date:  2009-03-18

10.  Genetic immunization elicits antigen-specific protective immune responses and decreases disease severity in Trypanosoma cruzi infection.

Authors:  Nisha Garg; Rick L Tarleton
Journal:  Infect Immun       Date:  2002-10       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.